CIK 0000811641 · Non-accelerated filer<br>Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010382980
- Phone
- 2078782770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | Gathagan Bryan K. Director | Purchase | +1,000 | $6.32 | $6K | 1,000 |
| 2025-06-11 | Basse Gloria F Director | Option exercise | +3,530 | $4.81 | $17K | 3,530 |
| 2025-06-11 | Basse Gloria F Director | Option exercise · Non Qualified Stock Options (Right to buy) | −11,470 | 3,530 | ||
| 2025-06-11 | Basse Gloria F Director | Option exercise · Non Qualified Stock Options (Right to buy) | −3.53 | 0 | ||
| 2025-04-16 | Gathagan Bryan K. Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | 10,000 | ||
| 2025-04-16 | Wainman Paul R Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | 10,000 | ||
| 2025-04-16 | Tomsche David Scott Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | 10,000 | ||
| 2025-04-16 | Brockmann Bobbi Jo VP of Sales and Marketing | Grant or award · Incentive Stock Options (Right to buy) | +5,000 | 5,000 | ||
| 2025-04-16 | Rosgen Steven T. Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | 10,000 | ||
| 2025-04-16 | Basse Gloria F Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | 10,000 | ||
| 2025-04-16 | Fiori Timothy C Chief Financial Officer | Grant or award · Incentive Stock Options (Right to buy) | +30,000 | $5.49 | $165K | 30,000 |
| 2024-09-20 | Wainman Paul R Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $3.60 | $36K | 10,000 |
| 2024-09-20 | Basse Gloria F Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $3.60 | $36K | 10,000 |
| 2024-09-20 | Tomsche David Scott Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $3.60 | $36K | 10,000 |
| 2024-09-20 | Gathagan Bryan K. Director | Grant or award · Non-Qualified Stock Options (Right to buy) | +10,000 | $3.60 | $36K | 10,000 |
| 2024-09-20 | Rosgen Steven T. Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $3.60 | $36K | 10,000 |
| 2024-08-28 | Tomsche David Scott Director | Returned to the company | +2,186 | $3.55 | $8K | 131,797 |
| 2024-08-23 | Tomsche David Scott Director | Returned to the company | +6,005 | $3.55 | $21K | 129,611 |
| 2024-08-22 | Tomsche David Scott Director | Returned to the company | +10,000 | $3.55 | $36K | 123,606 |
| 2024-08-19 | Tomsche David Scott Director | Returned to the company | +3,172 | $3.67 | $12K | 113,606 |
Page 2 of 11 · 209 trades